Literature Review: Efektivitas, Keamanan, dan Biaya Terapi Imidafenacin untuk Pasien Overactive Bladder
Imidafenacin is a new antimuscarinic agent in Indonesia that was recently approved in 2019 to treat overactive bladder (OAB) symptoms, including urinary incontinence, urinary frequency, and urinary urgency. As a new OAB medication in the Indonesian commercial market, a comprehensive review on the ef...
Sparad:
| Huvudupphov: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Indonésio |
| Utgiven: |
Politeknik Kesehatan Tanjung Karang
2020-12-01
|
| Serie: | Jurnal Kesehatan |
| Ämnen: | |
| Länkar: | https://ejurnal.poltekkes-tjk.ac.id/index.php/JK/article/view/2256 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|